d

ActaVirology

Acta Virology (AV) is a distinguished open-access journal focused on the latest developments in virology, epidemiology, and AI-driven disease modeling. It provides a platform for researchers to share groundbreaking findings on virus detection, vaccine development, and pandemic preparedness. AV emphasizes the role of artificial intelligence in virology research, fostering collaborations that enhance global health security and infectious disease management.

About the Journal

Acta Virology (AV) is a distinguished open-access journal focused on the latest developments in virology, epidemiology, and AI-driven disease modeling. It provides a platform for researchers to share groundbreaking findings on virus detection, vaccine development, and pandemic preparedness. AV emphasizes the role of artificial intelligence in virology research, fostering collaborations that enhance global health security and infectious disease management.

Current Issue

Vol. 1 No. 1 (2025): Emerging Trends in Antiviral Research

This issue highlights the latest advancements in the field of virology, focusing on innovative strategies to combat viral infections. Recent breakthroughs include the development of novel antiviral classes targeting essential viral enzymes, such as methyltransferases, which play a crucial role in RNA capping and viral replication. Additionally, research on broad-spectrum antivirals, like Bioxytran's Prolectin-M, which blocks viral entry by inhibiting galectins, offers promising solutions for treating a wide range of viruses. The issue also explores advancements in combination therapies, such as the use of protease inhibitors alongside other enzyme inhibitors, and discusses the potential of new technologies like lipid nanoparticles for drug delivery. These emerging trends not only enhance our understanding of viral mechanisms but also pave the way for more effective treatments against both current and future pandemics.

Published: 2025-03-11

View All Issues